Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2005-08-04
Original market date: See footnote 1
1999-06-28
Product name:
NOVOLINSET GE 30/70 INJ SUS
DIN:
02024446 Electronic product monograph is not available
Company:
NOVO NORDISK A/S
Novo Alle
Bagsvaerd
--
Denmark
2880
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Subcutaneous
Number of active ingredient(s):
2
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
68:20.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
A10AD01 INSULIN (HUMAN)
Active ingredient group (AIG) number:See footnote5
0223312003
Active ingredient(s) | Strength |
---|---|
INSULIN INJECTION HUMAN BIOSYNTHETIC | 30 UNIT / ML |
INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 70 UNIT / ML |